Author

D. E. Lind

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Aniszewska· 1 shared A. Schmidt· 1 shared A. Strömberg· 1 shared B. Hallberg· 1 shared E. Jennische· 1 shared G. Umapathy· 1 shared J. Guan· 1 shared J. Johansson· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Aniszewska

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ALK signalling primes the DNA damage response sensitizing ALK-driven neuroblastoma to ATR inhibition

M. Borenäs, G. Umapathy, D. E. Lind, W.-Y. Lai, J. Guan, J. Johansson, E. Jennische, A. Schmidt, Y. V. Kurhe, J. L. Gabre, A. Aniszewska, A. Strömberg, M. Bemark, M. N. Hall, J. Van den Eynden, , R. H. Palmer

This study identifies ALK signaling's role in enhancing DNA damage response in neuroblastoma, showing that combined ATR/ALK inhibition leads to sustained tumor response and differentiation.

bioRxiv · Aug 30, 2023 · PreprintCancer Biology